Recalls from ANI Pharmaceuticals, Inc.

• ANI Pharmaceuticals Hydroxyzine Hydrochloride Oral Solution (opens in a new tab)
  Low risk, FDA, Jun 24, 2026, Foreign object
• ANI Pharmaceuticals Estradiol Gel (opens in a new tab)
  Moderate risk, FDA, May 20, 2026, Packaging defect

Data: Recall Canary (opens in a new tab)